BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37017636)

  • 1. Oncogenic signaling is coupled to colorectal cancer cell differentiation state.
    Sell T; Klotz C; Fischer MM; Astaburuaga-García R; Krug S; Drost J; Clevers H; Sers C; Morkel M; Blüthgen N
    J Cell Biol; 2023 Jun; 222(6):. PubMed ID: 37017636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling the order of driver gene mutations in colorectal cancer.
    Li L; Hu Y; Xu Y; Tang S
    PLoS Comput Biol; 2023 Jun; 19(6):e1011225. PubMed ID: 37368936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer.
    Uhlitz F; Bischoff P; Peidli S; Sieber A; Trinks A; Lüthen M; Obermayer B; Blanc E; Ruchiy Y; Sell T; Mamlouk S; Arsie R; Wei TT; Klotz-Noack K; Schwarz RF; Sawitzki B; Kamphues C; Beule D; Landthaler M; Sers C; Horst D; Blüthgen N; Morkel M
    EMBO Mol Med; 2021 Oct; 13(10):e14123. PubMed ID: 34409732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
    Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
    ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity.
    Smit WL; Spaan CN; Johannes de Boer R; Ramesh P; Martins Garcia T; Meijer BJ; Vermeulen JLM; Lezzerini M; MacInnes AW; Koster J; Medema JP; van den Brink GR; Muncan V; Heijmans J
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25560-25570. PubMed ID: 32989144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
    Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
    Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential cancer mutations in cultured human intestinal stem cells.
    Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
    Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.
    Feng Y; Bommer GT; Zhao J; Green M; Sands E; Zhai Y; Brown K; Burberry A; Cho KR; Fearon ER
    Gastroenterology; 2011 Sep; 141(3):1003-1013.e1-10. PubMed ID: 21699772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncogenic phenoscape of colonic stem cell polarization.
    Qin X; Cardoso Rodriguez F; Sufi J; Vlckova P; Claus J; Tape CJ
    Cell; 2023 Dec; 186(25):5554-5568.e18. PubMed ID: 38065080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of key driver genes in colorectal cancer progression and metastasis.
    Huang D; Sun W; Zhou Y; Li P; Chen F; Chen H; Xia D; Xu E; Lai M; Wu Y; Zhang H
    Cancer Metastasis Rev; 2018 Mar; 37(1):173-187. PubMed ID: 29322354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer.
    Tong K; Pellón-Cárdenas O; Sirihorachai VR; Warder BN; Kothari OA; Perekatt AO; Fokas EE; Fullem RL; Zhou A; Thackray JK; Tran H; Zhang L; Xing J; Verzi MP
    Cell Rep; 2017 Dec; 21(13):3833-3845. PubMed ID: 29281831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
    Li P; Waldman SA
    Cancer Biol Ther; 2010 Aug; 10(3):211-8. PubMed ID: 20592492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
    Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer.
    Cabot D; Brun S; Paco N; Ginesta MM; Gendrau-Sanclemente N; Abuasaker B; Ruiz-Fariña T; Barceló C; Cuatrecasas M; Bosch M; Rentero C; Pons G; Estanyol JM; Capellà G; Jaumot M; Agell N
    Oncogene; 2021 Sep; 40(38):5730-5740. PubMed ID: 34333552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.